Protein intake and urinary albumin excretion rates in the EURODIAB IDDM Complications Study

被引:0
|
作者
M. Toeller
A. Buyken
G. Heitkamp
S. Brämswig
J. Mann
R. Milne
F. A. Gries
H. Keen
机构
[1] Diabetes Research Institute at the Heinrich-Heine-University,
[2] Clinical Department,undefined
[3] Düsseldorf,undefined
[4] Germany,undefined
[5] University of Otago,undefined
[6] Department of Nutrition,undefined
[7] Dunedin,undefined
[8] New Zealand,undefined
[9] Unit for Metabolic Medicine,undefined
[10] United Medical and Dental Schools,undefined
[11] Guy's Hospital Campus,undefined
[12] London,undefined
[13] UK,undefined
来源
Diabetologia | 1997年 / 40卷
关键词
Keywords Insulin-dependent diabetes mellitus; protein intake; urinary albumin excretion rate; diabetic nephropathy; diet recommendations; Europe.;
D O I
暂无
中图分类号
学科分类号
摘要
For people with insulin-dependent diabetes mellitus (IDDM) renal disease represents a life-threatening and costly complication. The EURODIAB IDDM Complications Study, a cross-sectional, clinic-based study, was designed to determine the prevalence of renal complications and putative risk factors in stratified samples of European individuals with IDDM. The present study examined the relationship between dietary protein intake and urinary albumin excretion rate (AER). Food intake was assessed centrally by a standardized 3-day dietary record. Urinary AER was determined in a central laboratory from a timed 24-h urine collection. Complete data were available from 2696 persons with IDDM from 30 centres in 16 European countries. In individuals who reported protein consumption less than 20 % of total food energy intake, mean AER was below 20 μg/min. In those in whom protein intake constituted more than 20 %, mean AER increased, a trend particularly pronounced in individuals with hypertension and/or poor metabolic control. Trends reached statistical significance for intakes of total protein (% of energy, p = 0.01) and animal protein (% of energy, p = 0.02), while no association was seen for vegetable protein (p = 0.83). These findings support the current recommendation for people with diabetes not to exceed a protein intake of 20 % of total energy. Monitoring and adjustment of dietary protein appears particularly desirable for individuals with AER exceeding 20 μg/min (approximately 30 mg/24 h), especially when arterial pressure is raised and/or diabetic control is poor. [Diabetologia (1997) 40: 1219–1226]
引用
收藏
页码:1219 / 1226
页数:7
相关论文
共 50 条
  • [1] Protein intake and urinary albumin excretion rates in the EURODIAB IDDM complications study
    Toeller, M
    Buyken, A
    Heitkamp, G
    Bramswig, S
    Mann, J
    Milne, R
    Gries, FA
    Keen, H
    Karamanos, B
    Tountas, C
    Kofinis, A
    Petrou, K
    Katsilambros, N
    RoussiPenessi, D
    Cignarelli, M
    Giorgino, R
    DeGeco, ML
    Ramunni, I
    IonescuTirgoviste, C
    Strachinariu, R
    Nicolau, A
    Tamas, G
    Kerenyi, Z
    Ahmed, AM
    Toth, J
    Kempler, P
    Muntoni, S
    Songini, M
    Stabilini, M
    Fossarello, M
    Pintus, S
    Ferriss, B
    Cronin, CC
    Humphreys, M
    Klischan, A
    Forst, T
    Schumacher, W
    Rottiers, R
    Priem, H
    Deschoolmeester, MJ
    Ebeling, P
    Sinisalo, M
    Koivisto, VA
    IdziorWalus, B
    Solnica, B
    SzopinskaCiba, L
    Solnica, K
    Krans, HMJ
    Lemkes, HHPJ
    Jansen, JJ
    DIABETOLOGIA, 1997, 40 (10) : 1219 - 1226
  • [2] BLOOD-PRESSURE, RETINOPATHY AND URINARY ALBUMIN EXCRETION IN IDDM - THE EURODIAB IDDM COMPLICATIONS STUDY
    STEPHENSON, JM
    FULLER, JH
    VIBERTI, GC
    SJOLIE, AK
    NAVALESI, R
    KARAMANOS, B
    TOUNTAS, C
    KOFINIS, A
    PETROU, K
    KATSILAMBROS, N
    GIORGINO, R
    CIGNARELLI, M
    DECICCO, M
    RAMUNNI, I
    IONESCUTIRGOVISTE, C
    IOSIF, CM
    PITEI, D
    BULIGESCU, S
    TAMAS, G
    KERENYI, Z
    AHMED, AM
    TOTH, J
    KEMPLER, P
    MUNTONI, S
    SONGINI, M
    STABILINI, M
    FOSSARELLO, M
    PINTUS, S
    MUNTONI, S
    FERRISS, JB
    CRONIN, CC
    WHYTE, AE
    CLEARY, PE
    TOELLER, M
    KLISCHAN, A
    FORST, T
    GRIES, FA
    WAGENER, W
    ROTTIERS, R
    PRIEM, H
    EBELING, P
    SINISALO, M
    KOIVISTO, VA
    IDZIORWALUS, B
    SOLNICA, B
    SZOPINSKACIBA, L
    SOLNICA, K
    KRANS, HMJ
    LEMKES, HHPJ
    JANSEN, JJ
    DIABETOLOGIA, 1995, 38 (05) : 599 - 603
  • [3] Plasma lipids and urinary albumin excretion rate in Type 1 diabetes mellitus: the EURODIAB IDDM Complications Study
    Mattock, MB
    Cronin, N
    Cavallo-Perin, P
    Idzior-Walus, B
    Penno, G
    Bandinelli, S
    Standl, E
    Kofinis, A
    Fuller, JH
    DIABETIC MEDICINE, 2001, 18 (01) : 59 - 67
  • [4] Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM complications study
    M. Greaves
    R. G. Malia
    K. Goodfellow
    M. Mattock
    L. K. Stevens
    J. M. Stephenson
    J. H. Fuller
    Complications Study Group EURODIAB IDDM
    Diabetologia, 1997, 40 : 698 - 705
  • [5] Fibrinogen and von Willebrand factor in IDDM: Relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: The EURODIAB IDDM complications study
    Greaves, M
    Malia, RG
    Goodfellow, K
    Mattock, M
    Stevens, LK
    Stephenson, JM
    Fuller, JH
    Karamanos, B
    Tountas, C
    Kofinis, A
    Petrou, K
    Katsilambros, N
    Giorgino, R
    Cignarelli, M
    DeCicco, ML
    Ramunni, I
    IonescuTirgoviste, C
    Iosif, CM
    Pitei, D
    Buligescu, S
    Tamas, G
    Kerenyi, Z
    Ahmed, AM
    Toth, J
    Kempler, P
    Muntoni, S
    Songini, M
    Stabilini, M
    Fossarello, M
    Pintus, S
    Ferriss, JB
    Cronin, CC
    Whyte, AE
    Cleary, PE
    Toeller, M
    Klischan, A
    Forst, T
    Gries, FA
    Rottiers, R
    Priem, H
    Ebeling, P
    Sinisalo, M
    Koivisto, VA
    IdziorWalus, B
    Solnica, B
    SzopinskaCiba, L
    Solnica, K
    Krans, HMJ
    Lemkes, HHPJ
    Jansen, JJ
    DIABETOLOGIA, 1997, 40 (06) : 698 - 705
  • [6] RETINOPATHY IN IDDM IN EUROPE, THE EURODIAB IDDM COMPLICATIONS STUDY
    SJOLIE, AK
    STEPHENSON, J
    ALDINGTON, S
    KOHNER, E
    JANKA, H
    STEVENS, L
    FULLER, J
    VISION RESEARCH, 1995, 35 : P338 - P338
  • [7] MICROVASCULAR AND ACUTE COMPLICATIONS IN IDDM PATIENTS - THE EURODIAB IDDM COMPLICATIONS STUDY
    STEPHENSON, J
    FULLER, JH
    DIABETOLOGIA, 1994, 37 (03) : 278 - 285
  • [8] NUTRITIONAL INTAKE IN IDDM PATIENTS - 1ST RESULTS FROM THE EURODIAB IDDM COMPLICATIONS STUDY
    TOELLER, M
    KLISCHAN, A
    HEITKAMP, G
    SCHUMACHER, W
    DIABETOLOGIA, 1992, 35 : A164 - A164
  • [9] The relationship of blood pressure to sodium and potassium excretion in the EURODIAB IDDM complications study.
    Colhoun, P
    Stevens, LK
    Mesa, FC
    Fuller, JH
    DIABETOLOGIA, 1997, 40 : 1441 - 1441
  • [10] Reductions in Weight and Protein Intake Lower Urinary Albumin Excretion: The PREMIER Study
    Chang, Alex
    Batch, Bryan
    Vollmer, William
    Svetkey, Laura
    Sanguankeo, Anawin
    Simpson, Crystal
    Appel, Lawrence
    CIRCULATION, 2013, 127 (12)